Nothing Special   »   [go: up one dir, main page]

JPH01233278A - Production of optically active alpha-tocotrienol - Google Patents

Production of optically active alpha-tocotrienol

Info

Publication number
JPH01233278A
JPH01233278A JP5798688A JP5798688A JPH01233278A JP H01233278 A JPH01233278 A JP H01233278A JP 5798688 A JP5798688 A JP 5798688A JP 5798688 A JP5798688 A JP 5798688A JP H01233278 A JPH01233278 A JP H01233278A
Authority
JP
Japan
Prior art keywords
compound
added
formula
mmol
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5798688A
Other languages
Japanese (ja)
Other versions
JP2685785B2 (en
Inventor
Kikumasa Sato
佐藤 菊正
Seiichi Inoue
誠一 井上
Toshiyuki Murayama
村山 俊幸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP5798688A priority Critical patent/JP2685785B2/en
Publication of JPH01233278A publication Critical patent/JPH01233278A/en
Application granted granted Critical
Publication of JP2685785B2 publication Critical patent/JP2685785B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pyrane Compounds (AREA)

Abstract

PURPOSE:To industrially readily obtain the subject compound of homologue of vitamin E in high yield, by subjecting to desulfurization reaction using novel compound obtained through several intermediates from readily available nerol as a starting material. CONSTITUTION:A compound expressed by formula III (R is protect group of OH) is generated by protecting 6-position OH in chroman ring of a compound expressed by formula II obtained from nerol as a starting material, then the compound is chlorinated and aminated with dimethylamine to obtain a novel compound expressed by formula IV. Next, the compound is oxidized with persulfuric acid, hydrogenolized and chlorinated to generate a novel compound expressed by formula VII, then reacted with geranylsulfone and resultant novel compound expressed by formula IX is subjected to desulfurization reaction by adding LiHBr3 and in the presence of dichloro[1,3-bis(diphenylphosphino) propane]palladium to obtain a novel compound expressed by formula X. Finally the compound is reacted with an acid such as hydrochloric acid, thus protect group of OH is eliminated and the compound expressed by formula I is obtained.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、工業的に有用な光学活性α−トコトリエノー
ルの新規な製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel method for producing industrially useful optically active α-tocotrienol.

〔従来の技術及び発明が解決しようとする課題〕トコト
リエノールはビタミンE同族体の一つであり、近年その
作用が注目されている。トコトリエノールはトコフェロ
ールと同様にα、β。
[Prior Art and Problems to be Solved by the Invention] Tocotrienols are one of the vitamin E homologs, and their effects have attracted attention in recent years. Tocotrienols are alpha and beta like tocopherols.

T、δの4種類が知られているが、これらのうちα−ト
コ) IJエノールが医薬品などの用途の点から鑑みて
最も重要である。
Four types are known: T and δ, but among these, α-IJ enol is the most important from the viewpoint of use in pharmaceuticals and the like.

このα−トコトリエノールの中で、天然型の光学活性d
−α−トコトリエノールは下記の構造式(1)を有して
いるが、 この構造式から明らかな如く、クロマン環の2位の位置
に不斉炭素を有していることから、従来光学活性d−α
−トコトリエノールを合成的に得ることは困難であった
Among this α-tocotrienol, the natural optical activity d
-α-Tocotrienol has the following structural formula (1), and as is clear from this structural formula, it has an asymmetric carbon at the 2-position of the chroman ring, so it has conventional optical activity d −α
-It has been difficult to obtain tocotrienols synthetically.

そこで本発明者等は、種々の方法について検討した結果
、一つの有力な方法として(E、 B、 E)−ゲラニ
ルゲラニオールを出発物質とする方法を完成し、特許出
頭を行った(日本特許出願昭和61年第206532号
)。
As a result of considering various methods, the present inventors completed a method using (E, B, E)-geranylgeraniol as a starting material as a promising method, and filed a patent application (Japanese patent application filed). No. 206532 of 1985).

しかしながら、この方法は有力な方法ではあるが、原料
に用いる([E、 B、 E)−ゲラニルゲラニオール
が人手困難であること、不斉点導入の際に高価な非天然
型酒石酸ジメチルを用いていること、及び鍵反応である
[2.3)シグマトロピー転位反応の収率があまりよく
ないことなどの問題点を有している。
However, although this method is a powerful method, it is difficult to obtain ([E, B, E)-geranylgeraniol as a raw material, and it requires the use of expensive non-natural dimethyl tartrate when introducing a chiral point. However, the yield of the key reaction [2.3) sigmatropic rearrangement reaction is not very good.

〔課題を解決するための手段〕[Means to solve the problem]

そこで本発明者等は、光学活性d−α=トコトリエノー
ルを合成的に得る工業的な方法について長年鋭意検討を
重ねた結果、出発物質として人手容易な(Z)−モノテ
ルペンアルコールの一つであるネロールを用いる工業的
な方法を見出し、本発明を完成した。
As a result of many years of intensive research into an industrial method for synthetically obtaining optically active d-α=tocotrienol, the present inventors found that it is one of the (Z)-monoterpene alcohols that can be easily used as a starting material. They discovered an industrial method using nerol and completed the present invention.

本発明方法の概要を説明すれば以下のとおりである。The outline of the method of the present invention is as follows.

H3 各工程を更に詳しく説明すれば以下のとおりである。H3 A more detailed explanation of each step is as follows.

(第一工程) 式(II)で示される(2R) −6−ヒドロキシ−2
−(4−メチル−3−ペンテニル)−2゜5、7.8−
テトラメチルクロマンのクロマン環の6位の水酸基を保
護する工程である。保護基として通常用いられる基を用
いる。例えば、ベンジル基、メトキシメチル基、エトキ
シメチルL p−二トロベンジル基、t−ブチルジメチ
ルシリル基、トリメチルシリル基、トリベンジルシリル
基などのトリ有機シリル基、2−テトラヒドロピラニル
基、2−テトラヒドロフラニル基、1−エトキシエチル
基などをあげることができるが、メトキシメチル基が最
も好ましい。
(First step) (2R)-6-hydroxy-2 represented by formula (II)
-(4-methyl-3-pentenyl)-2゜5,7.8-
This is a step of protecting the 6-position hydroxyl group of the chroman ring of tetramethylchroman. A group commonly used as a protecting group is used. For example, benzyl group, methoxymethyl group, ethoxymethyl L p-nitrobenzyl group, t-butyldimethylsilyl group, trimethylsilyl group, triorganosilyl group such as tribenzylsilyl group, 2-tetrahydropyranyl group, 2-tetrahydrofuranyl group. group, 1-ethoxyethyl group, etc., but methoxymethyl group is most preferred.

メトキシメチル基で保護する場合は、通常水酸化ナトリ
ウムの存在下にクロロメチルメチルエーテルを反応せし
める。
When protecting with methoxymethyl group, chloromethyl methyl ether is usually reacted in the presence of sodium hydroxide.

(第二工程) 本反応は、式(III)で示される化合物を、例えばト
リクロロインシアヌル酸を加えてクロル体とした後、ジ
メチルアミンを加えてアミノ化する反応である。
(Second Step) This reaction is a reaction in which the compound represented by formula (III) is converted into a chloride by adding, for example, trichloroincyanuric acid, and then dimethylamine is added to aminate the compound.

(第三工程) 第二工程で得られたアリルアミン体(IV)を酸化して
、化合物(V)を得る工程である。
(Third step) This is a step of oxidizing the allylamine compound (IV) obtained in the second step to obtain compound (V).

具体的には、例えばアリルアミン体(rV)を塩化メチ
レンに溶解し、炭酸ナトリウムを加えて冷却した後、過
酢酸を加えて反応を行う。この反応は通常−65℃前後
で行うことが好ましい結果を与える。
Specifically, for example, allylamine compound (rV) is dissolved in methylene chloride, sodium carbonate is added and cooled, and then peracetic acid is added to carry out the reaction. This reaction is usually carried out at around -65°C to give preferable results.

(第四工程) 得られた化合物(V)を、例えば酢酸に溶解し、亜鉛末
を加えO−N結合を水素化分解して化合物(VI)を得
る工程である。
(Fourth step) This is a step in which the obtained compound (V) is dissolved in, for example, acetic acid, zinc dust is added, and the O-N bond is hydrogenolyzed to obtain compound (VI).

(第五工程) 得られた化合物(Vl)をクロル化する工程である。(Fifth step) This is a step of chlorinating the obtained compound (Vl).

好ましい具体例を示せば、S−コリジンを用いて窒素置
換した後、例えば塩化リチウムなどの塩化物を加えてク
ロ、ル体とする。
To give a preferred specific example, after nitrogen substitution using S-collidine, a chloride such as lithium chloride is added to form a chloro, chloride.

(第六工程) 本反応は、第五工程で得られた化合物(VI)が有する
炭素鎖を伸長する反応である。
(Sixth Step) This reaction is a reaction that extends the carbon chain of the compound (VI) obtained in the fifth step.

具体的には、化合物(■)にゲラニルスルテトラn−ブ
チルアンモニウムブロマイドの存在下に反応せしめる。
Specifically, compound (■) is reacted in the presence of geranylsultetra n-butylammonium bromide.

(第七工程) 本反応は、脱硫反応である。(Seventh step) This reaction is a desulfurization reaction.

具体的には、化合物(IX)にジクロロ〔1,3−ビス
(ジフェニルホスフィノ)プロパン〕パラジウムを加え
、冷却後、例えばリチウムトリエチルボロヒドリド(L
iHBr3)を加えて反応を行う。
Specifically, dichloro[1,3-bis(diphenylphosphino)propane]palladium is added to compound (IX), and after cooling, for example, lithium triethylborohydride (L
iHBr3) is added to carry out the reaction.

(第八工程) 第七工程で得られた化合物(X)の水酸基の保護基を脱
離する反応であり、通常は塩酸など酸の存在下に反応を
行う。
(Eighth Step) This is a reaction in which the protecting group for the hydroxyl group of the compound (X) obtained in the seventh step is removed, and the reaction is usually carried out in the presence of an acid such as hydrochloric acid.

本発明方法において、α−トコトリエノールを製造する
際に用いる上記の出発物質(■)。
The above starting material (■) used in producing α-tocotrienol in the method of the present invention.

(V)、  (VT)、  (■)、  (IX)、 
 (X)などは、いずれも新規化合物である。
(V), (VT), (■), (IX),
(X) and the like are all new compounds.

本発明において出発物質として用いる光学活性体(n)
は、ネロールを出発物質として次のような方法で製造す
ることが可能である(特願昭61−206533号参照
)。
Optically active substance (n) used as a starting material in the present invention
can be produced by the following method using nerol as a starting material (see Japanese Patent Application No. 61-206533).

各工程を更に詳しく説明すれば以下の通りである。A more detailed explanation of each step is as follows.

(第一工程) ネロール(XI)にエナンシオセレクティブ・オキシデ
ーションの操作を行い、2,3−エポキシ体を得る。
(First step) Nerol (XI) is subjected to enantioselective oxidation to obtain a 2,3-epoxy compound.

具体的な方法の一例を示せば、ジクロロエタン、トリク
ロロエタンなどのハロゲン系炭化水素中で、ネロール、
酒石酸ジエステル体、オルトチタン酸テトライソプロピ
ル、及びt−ブチルハイドロパーオキサイドを〜70〜
30℃の温度で酸化を行う。酒石酸エステル体としては
、例えば酒石酸ジエチル、酒石酸ジメチルなどが利用で
きる。
To give an example of a specific method, nerol,
Tartrate diester, tetraisopropyl orthotitanate, and t-butyl hydroperoxide from ~70~
Oxidation is carried out at a temperature of 30°C. Examples of tartaric acid esters that can be used include diethyl tartrate and dimethyl tartrate.

(第二工程) 2.3−エポキシ体を還元的に開裂せしめ化合物(■)
を得る工程である。還元的に開裂せしめるには、例えば
水素化アルミニウムリチウムを用いれば好結果が得られ
る。この際溶媒としては、例えばジエチルエーテル、テ
トラヒドロフランなどのエーテル系溶媒を用い、温度は
特に限定されないが、通常は約−10℃〜40℃におい
て反応を行う。
(Second step) Compound (■) in which the 2.3-epoxy compound is reductively cleaved
This is the process of obtaining For reductive cleavage, good results can be obtained using, for example, lithium aluminum hydride. At this time, as the solvent, for example, an ether solvent such as diethyl ether or tetrahydrofuran is used, and the reaction is usually carried out at about -10°C to 40°C, although the temperature is not particularly limited.

(第三工程) 本工程は、化合物(′)ei)をトシル化し化合物(X
M)を得る工程である。通常の方法は、ピリジンなどの
存在下、p−)ルエンスルホニルクロリドを添加して反
応を行う。
(Third step) In this step, compound (')ei) is tosylated to form compound (X
This is the process of obtaining M). The usual method is to carry out the reaction by adding p-)luenesulfonyl chloride in the presence of pyridine or the like.

(第四工程) 本工程は、第三工程で得られた化合物(XI/)に金属
ナトリウムの存在下、イソプロピルメルカプタンを添加
してスルフィド(XV)を得る工程である。
(Fourth Step) This step is a step in which isopropyl mercaptan is added to the compound (XI/) obtained in the third step in the presence of metallic sodium to obtain sulfide (XV).

(第五工程) アセチル化工程であり、例えば無水酢酸などのアセチル
化剤によりアセチル化する。
(Fifth step) This is an acetylation step, in which, for example, acetylation is performed using an acetylating agent such as acetic anhydride.

(第六工程) 本工程は、第五工程で得られた化合物(Xlll)に、
(2,3]シグマトロピ一転位反応により4−アセトキ
シ−2,3,5−)リメチルフェノールを反応させる工
程である。
(Sixth step) In this step, the compound (Xllll) obtained in the fifth step is
This is a step in which 4-acetoxy-2,3,5-)limethylphenol is reacted by a (2,3]sigmatropy rearrangement reaction.

(第七工程) 本工程は、第六工程で得られた化合物(m)のイソプロ
ピルチオ基の除去と、脱アセチル化を行う工程である。
(Seventh Step) This step is a step in which the isopropylthio group of the compound (m) obtained in the sixth step is removed and deacetylated.

本工程はラネーニッケルなどを用いて還元的に脱硫し、
水素化アルミニウムリチウムなどを用いて還元的にアセ
チル基を除去する方法などで行う。
This process involves reductive desulfurization using Raney nickel, etc.
This is done by reductively removing the acetyl group using lithium aluminum hydride or the like.

(第八工程) 本工程は、最終目的物質である光学活性化合物(n)を
得る工程である。具体的には第七工程で得られた化合物
(XIX)をp−)ルエンスルホン酸、無水塩化亜鉛な
どを用いて直接環化せしめるか、又は酸化して、 構造式: で表されるキノン体を得た後に、例えばパラジウム/炭
素触媒及びp−)ルエンスルホン酸或いは無水塩化亜鉛
等により環化せしめることにより行う。
(Eighth Step) This step is a step of obtaining the optically active compound (n) which is the final target substance. Specifically, the compound (XIX) obtained in the seventh step is directly cyclized using p-)luenesulfonic acid, anhydrous zinc chloride, etc., or oxidized to obtain a quinone compound represented by the structural formula: After this is obtained, cyclization is carried out using, for example, a palladium/carbon catalyst and p-)luenesulfonic acid or anhydrous zinc chloride.

酸化工程に用いる酸化剤としては、例えば二酸化鉛、酸
化銀、過酸化水素、フレミー塩などを挙げることができ
るが、要するにヒドロキノン体をキノン体としうるよう
な酸化剤であればいかなるものでも使用可能である。
Examples of the oxidizing agent used in the oxidation step include lead dioxide, silver oxide, hydrogen peroxide, Flemy's salt, etc., but in short, any oxidizing agent that can convert hydroquinone to quinone can be used. It is.

〔発明の効果〕〔Effect of the invention〕

本発明方法によれば、dl−分割を必要とせず、容易に
光学活性α−トコ) IJエノールを製造することがで
きる。
According to the method of the present invention, optically active α-toco)IJ enol can be easily produced without the need for dl-resolution.

従って、本発明は工業的に光学活性α−トコトリエノー
ルを製造する方法であり、その価値は極めて高いもので
ある。
Therefore, the present invention is a method for industrially producing optically active α-tocotrienol, and its value is extremely high.

〔実 施 例〕〔Example〕

以下に実施例を掲げるが、本発明がそれのみに限定され
ることはないことは言うまでもない。
Examples are listed below, but it goes without saying that the present invention is not limited thereto.

実施例1 (2S、3R)−2,3−エポキシネロールの合成Y字
管、温度計、注射ずつを備えた300rn14つロフラ
スコに窒素を流しながら、塩化メチレン150mj!を
加え一20℃まで冷却した。まずオルトチタン酸イソプ
ロピル4.26g (15+y++nol) を加え、
次にL −(+)−酒石酸ジエチル3.40g (16
mmol)の塩化メチレン溶液477I72を同温度で
3分間で加えた後、10分間撹拌した。ネロール2.3
1g(15mmol)の塩化メチレン溶液3mj!を加
え、さらにt−ブチルヒドロペルオキシド(3,35M
の1,2−ジクロロエタン溶液) 9.00mj!(3
0mmol)を同温度で12分間で滴下し、4時間撹拌
した。系内に10%の酒石酸水溶液38mjl!を加え
30分間撹拌した後、室温に戻し、水層が透き通るまで
撹拌し、有機層と水層を分離した。水層を塩化メチレン
抽出しく30rnI!×3)、有機層ヲ合ワセテ洗浄(
水)、乾燥後(MgSL) 、溶媒留去してエーテル1
00m1を加え0℃まで冷却した。IN水酸化ナト’J
ウム水溶液45−を加え、30分間撹拌した後、有機層
と水層を分離して水層をエーテル抽出しく30rnl×
4)、有機層を合わせて洗浄(水、飽和ブライン)、乾
燥後(MgS04) 、溶媒留去して粗生成物を2.8
9g得た。カラムクロマトグラフィー(シリカゲル11
5g、 5〜10%酢酸エチル/ヘキサン)で精製して
上記標題の目的物2.04gを得た。
Example 1 Synthesis of (2S,3R)-2,3-Epoxynerol In a 300rn 14 flask equipped with a Y-tube, a thermometer, and a syringe, 150 mj of methylene chloride was added while flowing nitrogen. was added and cooled to -20°C. First, add 4.26 g of isopropyl orthotitanate (15+y++nol),
Next, 3.40 g (16
A methylene chloride solution of 477I72 (mmol) was added at the same temperature over 3 minutes, and then stirred for 10 minutes. Nerol 2.3
1g (15mmol) methylene chloride solution 3mj! was added, and further t-butyl hydroperoxide (3,35M
1,2-dichloroethane solution) 9.00mj! (3
0 mmol) was added dropwise over 12 minutes at the same temperature, and the mixture was stirred for 4 hours. 38 mjl of 10% tartaric acid aqueous solution in the system! was added and stirred for 30 minutes, then returned to room temperature, stirred until the aqueous layer became transparent, and the organic layer and the aqueous layer were separated. Extract the aqueous layer with methylene chloride for 30rnI! ×3), Wash the organic layer thoroughly (
Water), after drying (MgSL), the solvent was distilled off and ether 1
00ml was added and cooled to 0°C. IN Hydroxide Nato'J
After stirring for 30 minutes, the organic layer and aqueous layer were separated and the aqueous layer was extracted with ether.
4) The combined organic layers were washed (water, saturated brine), dried (MgSO4), and the solvent was distilled off to give a crude product of 2.8
I got 9g. Column chromatography (silica gel 11
5g, 5-10% ethyl acetate/hexane) to obtain 2.04g of the above-titled target product.

・収率;80% 6[(lrJ:2°’=−16,3°(cm1.002
. CHCI3)QIR(neat)cm−’ ; 3400、 2970. 1670. 1250. 1
030. 860・NMR(CCI4)  δ: 1.27(3H,s)、 1.35〜1.52(2H,
+++)、 1.60(38゜s)、 1..65(3
H,s)、 1.87〜2.27(2H,m)、 2.
03(IH,t、J=5Hz)、 3.58(2H,d
、J=5Hz)、 3.92(1!(、s)、 5゜0
0 (IH,t、 J=6.5Hz)実施例2 20rnI!ナスフラスコに(2S、3R)−2,3−
エポキシネロ−ル270mg (1,6+r+mo 1
)、無水酢酸1.5rllf(16mmol) 、ピリ
ジン1.5ml(19mmol)を加え、8.5時間室
温で撹拌した。メタノール2dを加えた後、水5mlに
あけ、有機層と水層を分離し、水層をエーテル抽出しく
2rnI!×4)、有機層を合わせて洗浄(2N塩酸、
水、飽和ブライン)、乾燥後(MgS04)、溶媒留去
した。得られた粗生成物をカラムクロマトグラフィー(
シリカゲル6g、溶出液;10%酢酸エチル/ヘキサン
)で精製して上記標題の目的物290mgを得た。
・Yield; 80% 6[(lrJ:2°'=-16,3°(cm1.002
.. CHCI3)QIR(neat)cm-'; 3400, 2970. 1670. 1250. 1
030. 860 NMR (CCI4) δ: 1.27 (3H, s), 1.35-1.52 (2H,
+++), 1.60 (38°s), 1. .. 65 (3
H, s), 1.87-2.27 (2H, m), 2.
03 (IH, t, J=5Hz), 3.58 (2H, d
, J=5Hz), 3.92(1!(,s), 5゜0
0 (IH, t, J=6.5Hz) Example 2 20rnI! (2S, 3R)-2,3- in an eggplant flask
Epoxy Nerol 270mg (1,6+r+mo 1
), 1.5 rllf (16 mmol) of acetic anhydride, and 1.5 ml (19 mmol) of pyridine were added, and the mixture was stirred at room temperature for 8.5 hours. After adding 2d of methanol, pour into 5ml of water, separate the organic layer and aqueous layer, and extract the aqueous layer with ether. ×4), Combine the organic layers and wash (2N hydrochloric acid,
water, saturated brine), dried (MgSO4) and evaporated. The obtained crude product was subjected to column chromatography (
Purification was performed using 6 g of silica gel (eluent: 10% ethyl acetate/hexane) to obtain 290 mg of the above-mentioned title compound.

・収率;95%、80%e、 e。・Yield: 95%, 80%e, e.

・IR(neat)cm−’ ; 2960、1740.1230.1030.880・N
MR(CCI4)  δ; 1.31(3H,s)、  1.40〜1.55(21
(、m)、  1.64(3H。
・IR(neat)cm-'; 2960, 1740.1230.1030.880・N
MR (CCI4) δ; 1.31 (3H, s), 1.40-1.55 (21
(, m), 1.64 (3H.

s)、  1.71(3H,s)、  1.91〜2.
29(2)1.m)、  2.06(3H,s)、  
2.81(IH,t、J=6Hz)、  3.92(L
H,dd。
s), 1.71 (3H, s), 1.91-2.
29(2)1. m), 2.06 (3H, s),
2.81 (IH, t, J=6Hz), 3.92 (L
H, dd.

J=6Hz、 12Hz)、  4.22 (IH,d
d、 J=6Hz、 12Hz)。
J=6Hz, 12Hz), 4.22 (IH, d
d, J=6Hz, 12Hz).

5、12 (1)1. t、 J=6.6Hz)ジオー
ル IH アリーン冷却器、温度計、滴下ロート、窒素法を備えた
500m14つロフラスコにテトラヒドロフラン100
mj!を入れ、水素化リチウムアルミニウム2.58g
 (68mmol)を加え懸濁させた。0℃まで冷却し
、(2R,3R) −2,3−エポキシネロール8.4
3g (49,5mmol)  のテトラヒドロフラン
溶液40mfを滴下し、10分間還流させ0℃まで冷却
し、水−テトラヒドロフラン(1: 1) 16rd!
で過剰の水素化リチウムアルミニウムをクエンチした。
5, 12 (1)1. t, J = 6.6 Hz) diol IH 100% tetrahydrofuran in a 500 m 14 round flask equipped with an Aline condenser, thermometer, dropping funnel and nitrogen method.
mj! and 2.58g of lithium aluminum hydride.
(68 mmol) was added and suspended. Cool to 0°C, (2R,3R)-2,3-epoxynerol 8.4
A solution of 3 g (49.5 mmol) in tetrahydrofuran (40 mf) was added dropwise, refluxed for 10 minutes, cooled to 0°C, and water-tetrahydrofuran (1:1) 16rd!
Excess lithium aluminum hydride was quenched with.

2N塩酸150−を加え有機層を分離して、水層をエー
テル抽出しく130m1’X4)、有機層を合わせて洗
浄(飽和ブライン)、乾燥後(MgSO4) 、溶媒留
去して上記標題の目的物を8.28g得た。なお、これ
は几C,IR,NMRスペクトルにより純粋であること
を確g忍した。
Add 2N hydrochloric acid (150°C) to separate the organic layer, extract the aqueous layer with ether (130ml x 4), combine the organic layers, wash (saturated brine), dry (MgSO4), and evaporate the solvent to obtain the above-mentioned purpose. 8.28g of the product was obtained. The purity of this product was confirmed by C, IR, and NMR spectra.

・収率;97% ・〔α〕67=−2.79°(C=2.19. CHC
l、)・IR(neat)cm ’ ; 3330、 2920.1120. 1060. 83
0− NMR(CC14)  δ; 1.17(31(、s)、 1.32〜2J3(6H,
m)、 1.59(3H。
・Yield; 97% ・[α]67=-2.79° (C=2.19.CHC
l,)・IR(neat)cm'; 3330, 2920.1120. 1060. 83
0-NMR (CC14) δ; 1.17 (31 (, s), 1.32-2J3 (6H,
m), 1.59 (3H.

s)、 3.72(2H,t、J=7Hz)、 4.4
0(2H,s)、 5.03(LH,t、 J=6Hz
) IH 塩化カルシウム管を備えた50m1ナスフラスコに(3
R) −3,7−シメチルー6−オクテンー1,3−ジ
オール7.98g(46mmol) 、ピリジン15m
j!を加え0℃に冷却し、トシルクロライド11.5g
(60mmol)を少量ずつ加えた。同温度で1.5時
間撹拌し、氷冷した水110rn1にあけ、有機層を分
離した。
s), 3.72 (2H, t, J=7Hz), 4.4
0(2H,s), 5.03(LH,t, J=6Hz
) In a 50 ml eggplant flask equipped with an IH calcium chloride tube (3
R) -3,7-dimethyl-6-octene-1,3-diol 7.98g (46mmol), pyridine 15m
j! was added and cooled to 0℃, and 11.5 g of tosyl chloride was added.
(60 mmol) was added little by little. The mixture was stirred at the same temperature for 1.5 hours, poured into 110 rn1 of ice-cooled water, and the organic layer was separated.

水層をエーテル抽出しく60m1x4)、有機層を合わ
せて洗浄(2N塩酸、水、飽和ブライン)、乾燥後(M
gSOn) 、溶媒留去して上記標題の目的物を15.
1g得た。なお、これはTLC,IR,NMRスペクト
ルにより純粋であることを確認した。
The aqueous layer was extracted with ether (60ml x 4), the organic layers were combined and washed (2N hydrochloric acid, water, saturated brine), dried (M
gSOn), the solvent was distilled off to obtain the above-titled target product in 15.
I got 1g. It was confirmed that this was pure by TLC, IR, and NMR spectra.

O収率; quant。O yield; quant.

OIR(neat)cm−’ ; 3550、2980.1600.1360.1190.
1180゜960、820 ・NMR(CCI 4)  δ; 1.10(3)1.s)、 1.23〜2.10(6H
,m)、 1.55(3)1゜s)、  1.63(3
H,s)、  2.17(3tl、s)、  2.50
(LH,s)。
OIR(neat)cm-'; 3550, 2980.1600.1360.1190.
1180°960, 820 ・NMR (CCI 4) δ; 1.10 (3) 1. s), 1.23-2.10 (6H
, m), 1.55(3)1゜s), 1.63(3
H, s), 2.17 (3tl, s), 2.50
(LH,s).

4.43(2tl、 t、 J=7Hz)、  4.9
7(IH,t、 J=7Hz)。
4.43 (2tl, t, J=7Hz), 4.9
7 (IH, t, J=7Hz).

7.20(2tl、d、J=8Hz)、  7.61(
2H,d、J=8Hz)JH アリーン冷却器、温度計、滴下ロートを備えた500r
rtl!4つロフラスコにメタノール140−を入れ、
金属ナトリウム2.12g(92mg原子)を溶解させ
インプロピルメルカプタン7、03g (92mmol
)を加えた後、室温で30分間撹拌した。(3R) −
3゜7−シメチルー3−ヒドロキシ−6−オクチニルト
シレート27.4g(84mmol)のメタノール溶液
60−を室温で45分間で滴下し、50℃で2時間撹拌
した。水400m1にあけエーテル抽出しく230m1
×4)、洗浄(IN水酸化ナト、リウム水溶液、飽和ブ
ライン)、乾燥後(MgS[14) 、溶媒留去して粗
生成物18.5gを得た。カラムクロマトグラフィー(
シリカゲル600g)で精製して上記標題の目的物を1
7.4g得た。
7.20 (2tl, d, J=8Hz), 7.61 (
2H, d, J = 8Hz) JH Aline 500r with cooler, thermometer and dropping funnel
rtl! Put methanol 140- into four Lof flasks,
7.03 g (92 mmol) of inpropyl mercaptan was dissolved by dissolving 2.12 g (92 mg atoms) of metallic sodium.
) and then stirred at room temperature for 30 minutes. (3R) -
A methanol solution of 27.4 g (84 mmol) of 3.7-dimethyl-3-hydroxy-6-octynyl tosylate was added dropwise at room temperature over 45 minutes, and the mixture was stirred at 50° C. for 2 hours. Pour into 400ml of water and extract ether, 230ml.
After washing (IN sodium hydroxide, lithium aqueous solution, saturated brine) and drying (MgS[14), the solvent was distilled off to obtain 18.5 g of a crude product. Column chromatography (
Purify with 600g of silica gel to obtain 1 of the above-titled target product.
7.4g was obtained.

・収率;90% −[al:” = −0,75°(cm3.73. C
OCl2)OIR(neat)cm−’ ; 3420、2970.1160.920.840ONM
R(CC1,)  δ; 1.16(3H,s)、 1.25(6H,d、J=7
Hz)、 1.37〜2.21(6H,m)、 1.6
0(3H,s)、 1.65(3)1.s)。
・Yield; 90% −[al:” = −0,75°(cm3.73.C
OCl2)OIR(neat)cm-'; 3420, 2970.1160.920.840ONM
R(CC1,) δ; 1.16 (3H, s), 1.25 (6H, d, J=7
Hz), 1.37-2.21 (6H, m), 1.6
0(3H,s), 1.65(3)1. s).

2.4(1〜2.57(2f(、rn)、 2.47<
II(、s)、 2.88(IN。
2.4(1~2.57(2f(,rn), 2.47<
II (, s), 2.88 (IN.

hept、、J=7Hz)、 5.07(IH,t、J
=6Hz)100mlナスフラスコに(3R) −3,
7−シメチルー3−ヒドロキシ−6−オクテニル イソ
プロピルスルフィド9.26g(40mmol) 、無
水酢酸5.33g(52mmol)を入れ、p−)ルエ
ンスルホン酸−水和物0.23g (1,2mmol)
を加えた後、室温で1時間撹拌した。反応液を水110
−にあけ、有機層と水層を分離した後、水層をエーテル
抽出しく60mI!×4)、有機層を合わせて洗浄(&
81和NaHCO,水溶液、水、飽和ブライン)、乾燥
後(MgS[14)、溶媒留去して粗生成物10.7g
を得た。カラムクロマトグラフィー(シリカゲル330
g、 15〜40%塩化メチレン/ヘキサン)で精製し
て上記標題の目的物を10.4g得た。
hept,, J=7Hz), 5.07(IH,t,J
= 6Hz) in a 100ml eggplant flask (3R) -3,
Add 9.26 g (40 mmol) of 7-dimethyl-3-hydroxy-6-octenyl isopropylsulfide and 5.33 g (52 mmol) of acetic anhydride, and add 0.23 g (1.2 mmol) of p-)luenesulfonic acid hydrate.
After adding, the mixture was stirred at room temperature for 1 hour. Add the reaction solution to 110% water.
After separating the organic and aqueous layers, the aqueous layer was extracted with ether at 60 mI! ×4), combine the organic layers and wash (&
81 hydrated NaHCO, aqueous solution, water, saturated brine), after drying (MgS [14), the solvent was evaporated to give 10.7 g of crude product.
I got it. Column chromatography (silica gel 330
15-40% methylene chloride/hexane) to obtain 10.4 g of the above-mentioned title product.

・収率;95% ・[ffl^’ =−2,02°(cm3.34. C
OCl2)OIR(neat)cm−’ ; 2960、1?30.1240.830・NMR(CD
CI、)δ; 1.26(6)1.d、J=6.8Hz)、 1.44
(3H,s)、 1.60(3H,s)、 1.68(
3H,s)、 1.72〜2.18(6H,m)。
・Yield; 95% ・[ffl^' = -2,02° (cm3.34.C
OCl2)OIR(neat)cm-'; 2960, 1?30.1240.830・NMR(CD
CI,)δ; 1.26(6)1. d, J=6.8Hz), 1.44
(3H,s), 1.60(3H,s), 1.68(
3H, s), 1.72-2.18 (6H, m).

1.98(3H,s)、 2.38〜2.L2(2)1
.m)、 2.94(1)1゜hept、、J=6.8
Hz)、  5.09(LH,m>(A 法) 7字管、注射すり、30mji側管付滴側管−ト、10
0mf 4つロフラスコを予め加熱乾燥し、窒素を流し
ながら室温まで冷却し、トリメチルヒドロキノン−4−
アセテート3.53g (18mmol)を塩化メチレ
ン15mj!に溶かし、3−アセトキシ−3゜7−ジメ
チル−6−オクテニル イソプロピルスルフィド1.6
5g (6mmo I)の塩化メチレン溶液8ml、S
−コリジン1.10g(9mmol)を加えた後、−5
0℃まで冷却した。塩化スルフリル0.98g (7m
mol)を滴下し、同温度で15分間撹拌後、トリエチ
ルアミン3.68g (36mmol)の塩化メチレン
溶液13m1を1.5分間で滴下、同温度で30分間撹
拌して徐々に室温に戻した。反応液を氷冷したIN塩酸
90mt’にあけ有機層を分離し、水層をエーテル抽出
しく5O−X4>、有機層を合わせて洗浄(飽和NaH
CO3水溶液、飽和ブライン)、乾燥後(MgSO4)
 、溶媒留去して粗生成物5.24gを得た。
1.98 (3H, s), 2.38-2. L2(2)1
.. m), 2.94(1)1゜hept,, J=6.8
Hz), 5.09 (LH, m> (A method) 7-shaped tube, injection pipe, 30mji side tube with drip side tube, 10
0 mf 4-hole flask was heated and dried in advance, cooled to room temperature while flowing nitrogen, and trimethylhydroquinone-4-
3.53g (18mmol) of acetate and 15mj of methylene chloride! Dissolve in 3-acetoxy-3゜7-dimethyl-6-octenyl isopropylsulfide 1.6
5 g (6 mmo I) in 8 ml of methylene chloride solution, S
- After adding 1.10 g (9 mmol) of collidine, -5
Cooled to 0°C. Sulfuryl chloride 0.98g (7m
After stirring at the same temperature for 15 minutes, 13 ml of a methylene chloride solution containing 3.68 g (36 mmol) of triethylamine was added dropwise over 1.5 minutes, stirring at the same temperature for 30 minutes, and gradually returning to room temperature. The reaction solution was poured into 90 mt of ice-cooled IN hydrochloric acid, the organic layer was separated, the aqueous layer was extracted with ether, and the organic layers were combined and washed (saturated NaH
CO3 aqueous solution, saturated brine), after drying (MgSO4)
The solvent was distilled off to obtain 5.24 g of a crude product.

カラムクロマトグラフィー(シリカゲル220g。Column chromatography (220 g of silica gel.

溶出液;5%酢酸エチル/ヘキサン)で精製して上記標
題の目的物0.90gを得た。
Purification with eluent (5% ethyl acetate/hexane) gave 0.90 g of the above-titled target product.

・収率;40% (B 法) Y字管、30mj!3つロフラスコ、100m!4つロ
フラスコを予め加熱乾燥し、窒素を流しながら室温まで
冷却し、トリメチルヒドロキノン−4−アセテ−) 2
.91g (15mmol)を塩化メチレン15−に溶
かし、3−アセトキシ−3,7−ジメチル−6−オクテ
ニルイソプロピルスルフィド1.36g(5mmol)
、S−コリジン0.72g (6mmo 1)を加え一
40℃まで冷却した。塩化スルフリル0.81g(6m
mol)を滴下し、同温度で10分間撹拌した後、この
反応液を予め一30℃まで冷却したトリエチルアミン5
.06g (50mmol)の塩化メチレン溶液1〇−
にそそぎ、徐々に0℃まで上昇させた。反応液を氷冷し
た2N塩酸70顎にあけ有機層を分離し、水層をクロロ
ホルム抽出しく20m7!X3)、有機層を合わせて洗
浄(NaHCO*水溶液)、乾燥後(MgSOJ、溶媒
留去して粗生成物を得た。カラムクロマトグラフィー(
シリカゲル300g、溶出液;5%酢酸エチル/ヘキサ
ン)で精製して上記標題の目的物を1.20g得た。
・Yield: 40% (Method B) Y-tube, 30mj! 3 Lof flasks, 100m! Heat and dry four flasks in advance, cool to room temperature while flowing nitrogen, and add trimethylhydroquinone (4-acetate) 2
.. Dissolve 91 g (15 mmol) in methylene chloride 15-, and 1.36 g (5 mmol) of 3-acetoxy-3,7-dimethyl-6-octenyl isopropylsulfide.
, 0.72 g (6 mmol) of S-collidine was added, and the mixture was cooled to -40°C. Sulfuryl chloride 0.81g (6m
mol) was added dropwise and stirred at the same temperature for 10 minutes, and the reaction solution was added with triethylamine 5, which had been cooled in advance to -30°C.
.. 06g (50mmol) methylene chloride solution 10-
The temperature was gradually raised to 0°C. Pour the reaction solution into a 70-mole tube of ice-cooled 2N hydrochloric acid, separate the organic layer, and extract the aqueous layer with chloroform. X3), the organic layers were combined, washed (NaHCO* aqueous solution), dried (MgSOJ), and the solvent was distilled off to obtain a crude product. Column chromatography (
Purification was performed using 300 g of silica gel (eluent: 5% ethyl acetate/hexane) to obtain 1.20 g of the above-mentioned target product.

(改 良 法) B法と同様に反応操作を行い、トリエチルアミンの塩化
メチレン溶液にそそぎ、徐々に0℃まで上昇させた。反
応液を減圧濾過して塩を濾別し、濾液を水にあけ有機層
を分離した。水層をエーテル抽出しく20m1’X2)
、有機層を合わせて乾燥後(MgSO4) 、溶媒留去
して粗生成物6gを得た。カラムクロマトグラフィー(
シリカゲル60g1溶出液;5%酢酸エチル/ヘキサン
)で精製して上記標題の目的物を1.64g得た。
(Improved method) The reaction operation was carried out in the same manner as in Method B, and the mixture was poured into a methylene chloride solution of triethylamine, and the temperature was gradually raised to 0°C. The reaction solution was filtered under reduced pressure to remove the salt, and the filtrate was poured into water to separate the organic layer. Extract the aqueous layer with ether (20m 1' x 2)
After combining the organic layers and drying (MgSO4), the solvent was distilled off to obtain 6 g of crude product. Column chromatography (
Purification was performed using 60 g of silica gel (1 eluent; 5% ethyl acetate/hexane) to obtain 1.64 g of the above-mentioned title compound.

・収 率;71% oIR(neat)cm−’ ; 3180、2930.1760.1730.1240.
830・NMR(CDCI、りδ; 1.09. 1.206)1.each d、J=7)
1z)、  1.3H3)1゜S)、 1.51(3H
,s)、 1.603H,s)、 1.68(4H,m
)。
- Yield; 71% oIR (neat) cm-'; 3180, 2930.1760.1730.1240.
830 NMR (CDCI, δ; 1.09. 1.206)1. each d, J=7)
1z), 1.3H3)1°S), 1.51(3H
,s), 1.603H,s), 1.68(4H,m
).

1.82(3H,s)、 1.94(2H,m)、 2
.00(3H,s)。
1.82 (3H, s), 1.94 (2H, m), 2
.. 00 (3H, s).

2.14(6tl、s)、 2.25(3H,s)、 
2.46〜3.03 (LH。
2.14 (6tl, s), 2.25 (3H, s),
2.46-3.03 (LH.

m)、 4.57(LH,t、J=6Hz)、 4.9
3(LH,m)、 7.57(IH,S) テート 実施例7に記載した改良法と同様の操作により上記標題
の目的物を1.84g得た。
m), 4.57 (LH, t, J=6Hz), 4.9
3 (LH, m), 7.57 (IH, S) 1.84 g of the above-titled target product was obtained by the same operation as the improved method described in Tate Example 7.

・収 率;79% ・図Δ’ =  13.1” (C=1.18. CH
Cl3)実施例9 アリーン冷却器、温度計を備えた5(1mj!2つロフ
ラスコにエタノール20rd、ラネーニッケル(W4)
9gを加え、20分間還流した。室温に戻した後、実施
例8で得られた転位生成物0.848 (L 8mmo
 l)のエタノール溶液10m1を加えて45分間撹拌
した。
・Yield; 79% ・Figure Δ' = 13.1" (C=1.18. CH
Cl3) Example 9 Ethanol 20rd, Raney nickel (W4) in a 5 (1 mj! 2 Lof flask) equipped with an Aline condenser and a thermometer.
9 g was added and refluxed for 20 minutes. After returning to room temperature, the rearrangement product obtained in Example 8 was 0.848 (L 8 mmo
10 ml of the ethanol solution of 1) was added and stirred for 45 minutes.

セライトを通して触媒を濾過し、溶媒留去して粗生成物
を得た。これをカラムクロマトグラフィー(シリカゲル
35g1溶出液;5%酢酸エチル/ヘキサン)で精製し
て上記標題の目的物を0、63g得た。
The catalyst was filtered through Celite and the solvent was evaporated to obtain the crude product. This was purified by column chromatography (35 g of silica gel, 1 eluent; 5% ethyl acetate/hexane) to obtain 0.63 g of the above-titled target compound.

・収 率;89% ・同名6=+15.4°(cm2.72.  CHCI
3)OIR(neat)cm−’ ; 3500、 2930. 1760. 1730. 1
210. 1070. 840・NMR(CDCl2)
δ; 1.48(3H,s)、  1.6H3H,s)、  
1.69(3H,s)。
・Yield: 89% ・Same name 6 = +15.4° (cm2.72. CHCI
3) OIR (neat) cm-'; 3500, 2930. 1760. 1730. 1
210. 1070. 840 NMR (CDCl2)
δ; 1.48 (3H, s), 1.6H3H, s),
1.69 (3H, s).

1.75〜1.98(6H,m)、 2.03(3H,
s)、 2.05(3H。
1.75-1.98 (6H, m), 2.03 (3H,
s), 2.05 (3H.

s)、  2.07(3H,s)、  2.13(3H
,s)、  2.33(3H,s)。
s), 2.07 (3H, s), 2.13 (3H
,s), 2.33(3H,s).

2.58(2H,t、J=8Hz)、  5.09(L
H,m)、  5.34(LH。
2.58 (2H, t, J=8Hz), 5.09 (L
H, m), 5.34 (LH.

S) 実施例1〇 一ヱヱ 温度計と窒素球を備えた200m1! 4つロフラスコ
にジエチルエーテル45m1を入れ、水素化リチウムア
ルミニウム0.59g (16mmol)を加え懸濁さ
せた。0℃に冷却し、実施例9で得られた脱硫体2.0
3g (5,2n+n+o l)のジエチルエーテル溶
液8ml!を滴下し、室温で1時間撹拌した。再び0℃
に冷却し、水5−を少量ずつ加えて過剰の水素化リチウ
ムアルミニウムをクエンチした後、2N塩酸70mj!
を加え、有機層を分離した。水層をエーテル抽出しく2
0rnlX3)、有機層を合わせて洗浄(亜ニチオン酸
ナトリウム水溶液、飽和ブライン)、乾燥後(MgSD
、) 、溶媒留去して粗生成物1、59gを得た。
S) Example 1〇1ヱ200m1 equipped with a thermometer and nitrogen bulb! 45 ml of diethyl ether was placed in a four-bottle flask, and 0.59 g (16 mmol) of lithium aluminum hydride was added and suspended. Desulfurized product 2.0 obtained in Example 9 was cooled to 0°C.
3g (5,2n+n+o l) in 8ml of diethyl ether solution! was added dropwise, and the mixture was stirred at room temperature for 1 hour. 0℃ again
The excess lithium aluminum hydride was quenched by adding water little by little, followed by 70mj of 2N hydrochloric acid!
was added and the organic layer was separated. Extract the aqueous layer with ether 2
After drying (MgSD
), the solvent was distilled off to obtain 59 g of crude product 1.

アリーン冷却器、温度計、窒素球を備えた100m14
つロフラスコに粗生成物1.59g (5,2mmol
)を入れベンゼン30mj!に溶解させて、さらにp−
トルエンスルホン酸−水塩99mg(0,52mmol
)を加えた。55℃で2時間撹拌した後、水30m1を
加え有機層を分離した。水層をエーテル抽出しく15−
X3)、有機層を合わせて洗浄(飽和NaHC[]3水
溶液、飽和ブライン)、乾燥後(MgSOs) 、溶媒
留去して粗生成物を得た。カラムクロマトグラフィー(
シリカゲル45g1溶出液;1%酢酸エチル/ヘキサン
)で精製して上記標題の目的物を1、39g得た。
100m14 with Aline cooler, thermometer and nitrogen bulb
1.59 g of crude product (5.2 mmol
) and 30mj of benzene! and further p-
Toluenesulfonic acid hydrate 99 mg (0.52 mmol
) was added. After stirring at 55° C. for 2 hours, 30 ml of water was added and the organic layer was separated. Extract the aqueous layer with ether 15-
X3), the organic layers were combined, washed (saturated aqueous NaHC[]3, saturated brine), dried (MgSOs) and evaporated to obtain the crude product. Column chromatography (
Purification was performed using 45 g of silica gel (1 eluent; 1% ethyl acetate/hexane) to obtain 1.39 g of the above-titled target product.

・収 率;93% ・融点; 4g、 5〜50℃ −[ff1g’ =−4,71°(cm1.40. C
HCI3)61R(KBr)cm−’ ; 3430、 2920. 1260. 1080. 8
55・NMR(CDC13)δ; 1.24(3H,s)、 1.54(2H,m)、 1
.60(3H,s)。
・Yield: 93% ・Melting point: 4g, 5-50°C -[ff1g' = -4,71°(cm1.40.C
HCI3)61R(KBr)cm-'; 3430, 2920. 1260. 1080. 8
55 NMR (CDC13) δ; 1.24 (3H, s), 1.54 (2H, m), 1
.. 60 (3H, s).

1.67(3H,s)、 1.77(2H,t、J=7
Hz)、 1.99(2H。
1.67 (3H, s), 1.77 (2H, t, J=7
Hz), 1.99 (2H.

m)、 2.10(6H,s)、 2.14(3)1.
s)、 2.60(2H,t。
m), 2.10 (6H, s), 2.14 (3) 1.
s), 2.60 (2H, t.

J=7Hz)、 4.29(1)1. s)、 5.1
2(LH,t、 J=7Hz)ヱヱ 塩化カルシウム管を備えた50m1l!ナスフラスコに
実施例1Oで得た(2R) −6−クロマノール309
mg(1,1mmol) 、無水酢酸219mg (2
,1mmol)、さらにp−トルエンスルホン酸−水塩
6 mg(0,03mmol)を加え、室温で1時間撹
拌した。メタノール1.5−を加え、水20m1にあけ
有機層を分離した。水層をエーテル抽出しく10mfx
3)、有機層を合わせて洗浄(飽和NaHCO3水溶液
、飽和ブライン)、乾燥後(MgS04)、溶媒留去し
て粗生成物355mgを得た。これをカラムクロマトグ
ラフィー(シリカゲル18g 、溶出液;1%酢酸エチ
ル/ヘキサン)で精製して上記標題の目的物を326m
g得た。
J=7Hz), 4.29(1)1. s), 5.1
2 (LH, t, J=7Hz)ヱヱ50ml with calcium chloride pipe! (2R)-6-chromanol 309 obtained in Example 1O in an eggplant flask
mg (1.1 mmol), acetic anhydride 219 mg (2
, 1 mmol) and 6 mg (0.03 mmol) of p-toluenesulfonic acid hydrate were added thereto, and the mixture was stirred at room temperature for 1 hour. 1.5 methanol was added, and the mixture was poured into 20 ml of water, and the organic layer was separated. Extract the aqueous layer with ether at 10mfx
3) The combined organic layers were washed (saturated aqueous NaHCO3, saturated brine), dried (MgSO4), and the solvent was evaporated to obtain 355 mg of crude product. This was purified by column chromatography (18 g of silica gel, eluent: 1% ethyl acetate/hexane) to obtain 326 m
I got g.

・収率;92% iR(neat)cm−’  ; 2940、1?55.1210.1080.850・N
MR(CDC13)δ; 1.20(3H,s)、  1.58(3f1.s)、
  1.64(3H,s)。
・Yield; 92% iR (neat) cm-'; 2940, 1?55.1210.1080.850・N
MR (CDC13) δ; 1.20 (3H, s), 1.58 (3f1.s),
1.64 (3H, s).

1.90(3H,s)、  1.96(3H,s)、 
 2.07(3H,s)。
1.90 (3H, s), 1.96 (3H, s),
2.07 (3H, s).

2.17(3H,s)、  1.41〜2.33(6H
,m)、  2.38(2H。
2.17 (3H, s), 1.41-2.33 (6H
, m), 2.38 (2H.

t、J=7Hz)、  5.10(lft、m)ガラス
管、塩化カルシウム管、温度計を備えた30mN3つロ
フラスコに実施例11で得た(2R)−6−アセトキシ
クロマン320mg (0,97mmol)、塩化メチ
レン5−を加え、−60℃まで冷却しオゾン酸素(3,
6mg/ Rガス)を8.5 f /hで1時間流した
。その後、窒素でオゾンを追い出し、同温度でジメチル
スルフィド120mg (1,94mmol)を加えて
徐々に室温に戻し、水20rnlにあけ有機層を分離し
た。水層をエーテル抽出しく7rrti!X3)、有機
層を合わせて洗浄(水、飽和ブライン)、乾燥後(Mg
SO4) 、溶媒留去して粗生成物343mgを得た。
t, J = 7 Hz), 5.10 (lft, m) 320 mg (0.97 mmol) of (2R)-6-acetoxychroman obtained in Example 11 was placed in a 30 mN three-low flask equipped with a glass tube, a calcium chloride tube, and a thermometer. ), methylene chloride 5- was added, cooled to -60℃ and ozone oxygen (3,
6 mg/R gas) was flowed at 8.5 f/h for 1 hour. Thereafter, ozone was expelled with nitrogen, 120 mg (1.94 mmol) of dimethyl sulfide was added at the same temperature, the temperature was gradually returned to room temperature, and the mixture was poured into 20 rnl of water to separate the organic layer. 7rrti to extract the aqueous layer with ether! X3), the combined organic layers were washed (water, saturated brine), and after drying (Mg
SO4) and the solvent was distilled off to obtain 343 mg of crude product.

これをカラムクロマトグラフィー(シリカゲル16g)
で精製して上記標題の目的物を178mg得た。
Column chromatography (silica gel 16g)
Purification was performed to obtain 178 mg of the above-mentioned target product.

・収 率;60% (オゾン基準 収率91%) OI R(neat) cm−’  ;2930、 2
720. 1745. 1720. 1215. 11
95゜・NMR(CDC13)δ; 1.21(3H,s)、 1.77(2H,t、J=6
.8Hz)、 1.84〜1.97(2H,m)、 1
.97(3H,s)、 2.旧(3t1.s)。
・Yield: 60% (Ozone standard yield: 91%) OIR(neat) cm-'; 2930, 2
720. 1745. 1720. 1215. 11
95° NMR (CDC13) δ; 1.21 (3H, s), 1.77 (2H, t, J = 6
.. 8Hz), 1.84-1.97 (2H, m), 1
.. 97 (3H, s), 2. Old (3t1.s).

2、30 (3H,s) 、 2.60 (4H,m)
 、 9.74 (18,t、 J=1、6Hz) モレキニラーシーブス4A入りトラップ球、ジムロート
を備えた50m1!ナスフラスコに、実施例12で得た
(2S)−アルデヒド体150mg(0,49mmol
) 、ベンゼン15mj!、エチレングリコール37m
g (0,59mmo 1)、さらにp−トルエンスル
ホン酸−水塩6 mg (0,03mmol)を加えて
2時間還流した。
2,30 (3H,s), 2.60 (4H,m)
, 9.74 (18, t, J = 1, 6 Hz) 50m1 with a trap ball containing Molekinilar Thieves 4A and Jim Roth! In an eggplant flask, 150 mg (0.49 mmol) of the (2S)-aldehyde obtained in Example 12 was added.
), benzene 15mj! , ethylene glycol 37m
g (0.59 mmol 1) and further 6 mg (0.03 mmol) of p-toluenesulfonic acid hydrate were added thereto and the mixture was refluxed for 2 hours.

室温に戻して洗浄(IN NazCO,水溶液、水)、
乾燥後(MgSOl)、溶媒留去して粗生成物166m
gを得、カラムクロマトグラフィー(シリカゲル6g、
溶出液;10%酢酸エチル/ヘキサン)で精製して上記
標題の目的物を143+ng得た。
Return to room temperature and wash (IN NazCO, aqueous solution, water),
After drying (MgSOl), the solvent was distilled off to give a crude product of 166m
g was obtained, and column chromatography (6 g of silica gel,
Purification was performed using 10% ethyl acetate/hexane (eluent: 10% ethyl acetate/hexane) to obtain 143+ng of the above-mentioned title object.

・収率;84% ・融点;131〜132℃ −NMR(CDCI、)δ; 1.24(3H,s)、 1.76(4H,m)、 1
.78(2)1.t、J=6.6Hz)、 1.97(
3H,s)、 2.0H3H,s)、 2.08(3H
,s)、 2.32(3H,s)、 2.61(2H,
t、J=6.6Hz)。
・Yield: 84% ・Melting point: 131-132°C -NMR (CDCI,) δ: 1.24 (3H, s), 1.76 (4H, m), 1
.. 78(2)1. t, J=6.6Hz), 1.97(
3H,s), 2.0H3H,s), 2.08(3H
,s), 2.32(3H,s), 2.61(2H,
t, J=6.6Hz).

3.73〜3.89(2H,m)、  3.93〜4.
08(2)1.m)。
3.73-3.89 (2H, m), 3.93-4.
08(2)1. m).

4、87 (IH,m) 温度計、窒素法を備えた30m13つロフラスコにジエ
チルエーテル6rd!、水素化リチウムアルミニウム2
2mgを加え懸濁させた。0℃まで冷却し、実施例13
で得た(2S)−アセタール体135mg(0,35m
mol)のジエチルエーテル−塩化メチレン溶液4−を
滴下し、室温で40分間撹拌した。再び0℃まで冷却し
水1ml!で過剰の水素化リチウムアルミニウムをクエ
ンチし、2N塩酸8ml!を加えて有機層を分離した。
4,87 (IH, m) Diethyl ether 6rd in a 30m 13-hole flask equipped with a thermometer and nitrogen method! , lithium aluminum hydride 2
2 mg was added and suspended. Cool to 0°C, Example 13
135 mg (0.35 m
mol) of diethyl ether-methylene chloride solution 4- was added dropwise, and the mixture was stirred at room temperature for 40 minutes. Cool again to 0℃ and add 1ml of water! Quench excess lithium aluminum hydride with 8 ml of 2N hydrochloric acid! was added to separate the organic layer.

水層をエーテル抽出しく7rdX3)、有機層を合わせ
て洗浄(水)、乾燥後(MgSO4) 、溶媒留去して
粗生成物を得た。これをカラムクロマトグラフィー(シ
リカゲル4g、溶出液;10%酢酸エチル/ヘキサン)
で精製して上記標題の目的物を113mg得た。
The aqueous layer was extracted with ether (7rdX3), the organic layers were combined, washed (water), dried (MgSO4), and the solvent was distilled off to obtain a crude product. This was subjected to column chromatography (4 g of silica gel, eluent: 10% ethyl acetate/hexane).
Purification was performed to obtain 113 mg of the above-mentioned target product.

・収 率;95% ・融点; 102.5〜104℃ ・IR(KBr)cm−’ ; 3480、2920.1240.1130.920・N
MR(CDC13)δ; 1.23(3)1.s)、 1.75(4H,m)、 
1.79(2H,t、J=7Hz)、 2.10(6H
,s)、 2.14(31(、s)、 2.61(2H
・Yield: 95% ・Melting point: 102.5-104°C ・IR (KBr) cm-'; 3480, 2920.1240.1130.920・N
MR(CDC13)δ; 1.23(3)1. s), 1.75 (4H, m),
1.79 (2H, t, J=7Hz), 2.10 (6H
,s), 2.14(31(,s), 2.61(2H
.

t、J=7Hz)、 3.73〜3.88(28,m)
、 3.93〜4.08(2N、m)、 4.29(L
H,s)、 4.86(IH,m)ジムロートを備えた
20m1ナスフラスコに実施例14で得た(2S)−ア
セタール体11hg (0,36mmol) 、アセト
ン8ml、IN塩酸180μAを加え、4時間還流した
。室温まで戻し、飽和炭酸水素ナトリウム水溶液2−を
加えて有機層を分離した。水層をエーテル抽出しく6m
1l!X3)、有機層を合わせて洗浄(飽和NaHCO
+水溶液、水)、乾燥後(MgSIL) 、溶媒留去し
て粗生成物を得た。これをカラムクロマトグラフィー(
シリカゲル4g)で精製して上記標題の目的物を76m
g得た。
t, J=7Hz), 3.73-3.88 (28, m)
, 3.93-4.08 (2N, m), 4.29 (L
11 hg (0.36 mmol) of the (2S)-acetal obtained in Example 14, 8 ml of acetone, and 180 μA of IN hydrochloric acid were added to a 20 ml eggplant flask equipped with a 4.86 (IH, m) Dimroth. Refluxed for an hour. The temperature was returned to room temperature, saturated aqueous sodium hydrogen carbonate solution 2- was added, and the organic layer was separated. Extract the aqueous layer with ether 6 m
1l! X3), combine the organic layers and wash (saturated NaHCO
After drying (MgSIL), the solvent was distilled off to obtain a crude product. Column chromatography (
Purify with 4g of silica gel to obtain 76m of the above-titled target product.
I got g.

・収 率;81% ・融点;88〜89.5℃ ・[(rl呂’ =  13.4°(cm1.15. 
C5Hs)、 79%e、 e。
・Yield: 81% ・Melting point: 88-89.5°C ・[(rlRo' = 13.4° (cm1.15.
C5Hs), 79%e, e.

く文献値〉 融点; 90.5〜92.5℃ [ff1a5=−17,02°(cm0.9398. 
C,H6)ルクロマン 塩化カルシウム管を備えた50−ナスフラスコに実施例
10で得た6−クロマノール1.62g (5,6mm
ol)を入れ、テトラヒドロフラン16mI!、ジメチ
ルスルホキシド0.32m1’に溶解させ、水素化ナト
リウム(55%)を149g (llmmol)加え、
室温で30分間反応させた後、クロロメチルメチルエー
テル0.958 (llmmol)を滴下して0.5時
間撹拌した。反応液を水にあけ有機層を分離して、水層
を塩化メチレン抽出し、有機層を合わせて洗浄(飽和ブ
ライン)、乾燥後(MgSO4) 、溶媒留去して粗生
成物を得た。これをカラムクロマトグラフィー(シリカ
ゲル30g1溶出液;2%酢酸エチル/ヘキサン)で精
製して上記標題の目的物を1.83g得た。
Literature value> Melting point; 90.5-92.5°C [ff1a5=-17,02° (cm0.9398.
C, H6) 1.62 g of 6-chromanol obtained in Example 10 (5.6 mm
ol) and 16 mI of tetrahydrofuran! , dissolved in 0.32 ml of dimethyl sulfoxide, added 149 g (llmmol) of sodium hydride (55%),
After reacting at room temperature for 30 minutes, 0.958 (llmmol) of chloromethyl methyl ether was added dropwise and stirred for 0.5 hour. The reaction solution was poured into water, the organic layer was separated, the aqueous layer was extracted with methylene chloride, the organic layers were combined, washed (saturated brine), dried (MgSO4), and the solvent was distilled off to obtain a crude product. This was purified by column chromatography (30 g of silica gel, 1 eluent; 2% ethyl acetate/hexane) to obtain 1.83 g of the above-titled target product.

・収率;98% OI R(neat) cnr ’  ;2920、1
260.1160.1050.980・NMR(CDC
Iりδ; 1.24(3H,s)、  1.54(2H,m)、 
 1.58(3H,s)。
・Yield: 98% OI R(neat) cnr'; 2920, 1
260.1160.1050.980 NMR (CDC
Iri δ; 1.24 (3H, s), 1.54 (2H, m),
1.58 (3H, s).

1.67(3H,s)、  1.77(2)1.t、J
=7Hz)、  2.09(3N。
1.67 (3H, s), 1.77 (2) 1. t, J
=7Hz), 2.09 (3N.

s)、  2.14(3H,s)、  2.18(3H
,s)、  2.57(2H,t。
s), 2.14 (3H, s), 2.18 (3H
,s), 2.57(2H,t.

J=7Hz)、  3.60(3H,s)、  4.8
4(2H,s)、  5.12(LH,m) 20mlナスフラスコに実施例16で得たメトキシメチ
ルエーテル体0.60g (1,8mmol)を入れ、
ヘキサン3.5rnflに溶かし、水浴で冷却してトリ
クロロイソシアヌル酸0. l1g(0,48+++m
ol)を加え、3.5時間撹拌した。反応液を濾過して
有機層を洗浄(Na2S203水溶液、飽和ブライン)
、乾燥後(MgSO<) 、溶媒留去してクロル体0.
66gを得た。
J=7Hz), 3.60 (3H, s), 4.8
4 (2H, s), 5.12 (LH, m) 0.60 g (1.8 mmol) of the methoxymethyl ether obtained in Example 16 was placed in a 20 ml eggplant flask,
Trichloroisocyanuric acid was dissolved in 3.5 rnfl of hexane and cooled in a water bath. l1g (0,48+++m
ol) was added and stirred for 3.5 hours. Filter the reaction solution and wash the organic layer (Na2S203 aqueous solution, saturated brine)
After drying (MgSO<), the solvent was distilled off to give 0.0% chloride.
66g was obtained.

30−ナスフラスコにクロル体0.43g(2mmoり
を入れ、メタノール6m1l!に溶かし、50%ジメチ
ルアミン水溶液3.4−を加えて室温で6日間撹拌した
。溶媒留去後、IN水酸化ナトリウム水溶液5rd!に
あけ、酢酸エチル抽出して乾燥後(MgSOs)、溶媒
留去し、粗生成物を得た。これをカラムクロマトグラフ
ィー(シリカゲル8g1溶出液;50%酢酸エチル/ヘ
キサン)で精製して上記標題の目的物を0.22g得た
0.43 g (2 mmol) of the chloride was placed in a 30-bottom eggplant flask, dissolved in 6 ml of methanol, and 3.4-ml of a 50% aqueous dimethylamine solution was added, followed by stirring at room temperature for 6 days. After distilling off the solvent, IN sodium hydroxide was added. After pouring into the aqueous solution 5rd!, extracting with ethyl acetate and drying (MgSOs), the solvent was distilled off to obtain a crude product. This was purified by column chromatography (8 g of silica gel, 1 eluent; 50% ethyl acetate/hexane). 0.22 g of the above-titled target product was obtained.

・収率;60% iR(neat)cm−’  ; 2920、 1660. 1240. 1160. 1
050. 980・ NMR(CDCl2) δ : 1.203H,s)、 1.44〜1.93(6H,m
)、 1.68(3)1.s)、 2.08(3)1.
s)、 2.14(3H,s)、 2.18(3H,s
)、 2.2H6H,s)、2.30〜2.81 (3
H,m) 。
-Yield; 60% iR(neat)cm-'; 2920, 1660. 1240. 1160. 1
050. 980 NMR (CDCl2) δ: 1.203H, s), 1.44-1.93 (6H, m
), 1.68(3)1. s), 2.08(3)1.
s), 2.14(3H,s), 2.18(3H,s
), 2.2H6H,s), 2.30-2.81 (3
H, m).

3.6H3H,s)、 4.80(IH,s)、 4.
86(3H,s)キシメトキシ−2,5,7,8−テト
ラメチルクロマヱ 塩化カルシウム管を備えた50mj!3つロフラスコに
実施例17で得たアリルアミンを0.32g (0,8
5mmol)入れ、塩化メチレン12−に溶かし、炭酸
ナトリウム0.18g(1,7mmol)を加え一65
℃まで冷却した。同温度で40%過酢酸0.32g (
1,7mmol)を加え、1時間撹拌後0℃までゆっく
り昇温させ亜硫酸ナトリウム0.16g (1,27m
mol)の5mj水溶液を加えた。有機層を分離後、水
層に食塩を加え酢酸エチルで抽出して、乾燥後(MgS
O,) 、40〜50℃に加熱して1時間反応させた。
3.6H3H,s), 4.80(IH,s), 4.
86(3H,s)Xymethoxy-2,5,7,8-tetramethylchromade 50mj with calcium chloride tube! 0.32 g of allylamine obtained in Example 17 (0.8
5 mmol), dissolved in 12-methylene chloride, and added 0.18 g (1.7 mmol) of sodium carbonate.
Cooled to ℃. At the same temperature, 0.32 g of 40% peracetic acid (
After stirring for 1 hour, the temperature was slowly raised to 0°C, and 0.16 g (1.27 mmol) of sodium sulfite was added.
A 5 mj aqueous solution of mol) was added. After separating the organic layer, salt was added to the aqueous layer, extracted with ethyl acetate, and after drying (MgS
O, ), heated to 40-50°C and reacted for 1 hour.

溶媒留去して得られた粗生成物をカラムクロマトグラフ
ィー(シリカゲル5.5g、溶出液;8%酢酸エチル/
ヘキサン)で精製して上記標題の目的物を0、20g得
た。
The crude product obtained by distilling off the solvent was subjected to column chromatography (5.5 g of silica gel, eluent: 8% ethyl acetate/
Hexane) to obtain 0.20 g of the above-mentioned target product.

・収率;61% OIR(neat)cm−’  ; 2900、 1210. 860 ・NMR(CDC13)δ; 1.25(3H,s)、  1.66(3H,s)、 
 1.50〜1.86 (4N。
- Yield; 61% OIR (neat) cm-'; 2900, 1210. 860 ・NMR (CDC13) δ; 1.25 (3H, s), 1.66 (3H, s),
1.50-1.86 (4N.

m)、  2.09(3H,s)、  2.14(3H
,s)、  2.18(3H,s)。
m), 2.09 (3H, s), 2.14 (3H
,s), 2.18(3H,s).

2.57(6H,s)、  2.54〜2.66(2)
1.m)、  3.61(3H。
2.57 (6H, s), 2.54-2.66 (2)
1. m), 3.61 (3H.

s)、  4.04(2H,s)、  4.85(28
,s)、  5.44(IH,t。
s), 4.04 (2H, s), 4.85 (28
, s), 5.44 (IH, t.

J=6.3Hz) 10−ナスフラスコに実施例18で得たアリルオキシア
ミン0.19g (0,49mmol)を入れ、酢酸−
水(1:1)5.4mlに溶かして亜鉛末0.90g 
(14mmol)を加えた。室温で40時間撹拌した後
、亜鉛末を濾別し、濾液をエーテル抽出、洗浄(飽和N
aHCOs水溶液、飽和ブライン)、乾燥後(M g 
S 04 ) 、溶媒留去して粗生成物を得た。これを
カラムクロマトグラフィー(シリカゲル4.7g、溶出
液;10%酢酸エチル/ヘキサン)で精製して上記標題
め目的物を0.12g得た。
J = 6.3 Hz) 0.19 g (0.49 mmol) of allyloxyamine obtained in Example 18 was placed in a 10-bottom flask, and acetic acid-
0.90g of zinc powder dissolved in 5.4ml of water (1:1)
(14 mmol) was added. After stirring at room temperature for 40 hours, the zinc dust was filtered off, and the filtrate was extracted with ether and washed (saturated N
aHCOs aqueous solution, saturated brine), after drying (M g
S 04 ) and the solvent was distilled off to obtain a crude product. This was purified by column chromatography (4.7 g of silica gel, eluent: 10% ethyl acetate/hexane) to obtain 0.12 g of the title target compound.

尚、上記の亜鉛末としては、亜鉛末を5%塩酸中、数分
間撹拌した後濾過し、さらに洗浄(蒸留水×3、メタノ
ール×3、エーテルX3)したものを使用した。
The above-mentioned zinc powder used was one that was stirred in 5% hydrochloric acid for several minutes, filtered, and then washed (distilled water x 3, methanol x 3, ether x 3).

・収率;73% OI R(neat) cm−’  ;3350、 2
900. 1240. 1160. 1060. 85
0・NMR(CDCI 、)δ; 1.26(3H,s)、 1.58(LH,s)、 1
.65(3tl、s)。
・Yield; 73% OIR(neat) cm-'; 3350, 2
900. 1240. 1160. 1060. 85
0.NMR (CDCI,) δ; 1.26 (3H, s), 1.58 (LH, s), 1
.. 65 (3tl, s).

1.51〜1.65(28,m)、 1.80(2N、
t、J=7Hz)。
1.51-1.65 (28, m), 1.80 (2N,
t, J=7Hz).

2.09(3H,s)、 2.14(3H,s)、 2
.18(3tl、s)。
2.09 (3H, s), 2.14 (3H, s), 2
.. 18 (3tl, s).

2.59(2H,t、J=7Hz)、 3.61(3H
,s)、 3.97(2H。
2.59 (2H, t, J=7Hz), 3.61 (3H
, s), 3.97 (2H.

S)、 4.85(2H,s)、 5.40(lft、
m)ペンテニル)−6−メドキシメトキシー2.5.7
゜10m1ナスフラスコに実施例19で得た(EE) 
−アリルアルコール体120rig(0,34+n+n
ol) 、S −:1リジン92mg (0,75mm
o 1)を入れ窒素置換した。さらに塩化リチウム29
mg t’o、 69mmo I)のジメチルポルムア
ミド溶液1.5mj!を加え水浴で冷却した後塩化メタ
ンスルホニル79mg (0,69mmol)を加えて
水浴で冷却したまま3.5時間撹拌した。反応液を30
−の氷水にあけ、エーテル抽出、洗浄(飽和Cu(NO
3)、水溶液、飽和Na)lc[Is水溶液、水)、乾
燥後(MgSIL) 、溶媒留去して上記標題の目的物
を126mg得た。このものはTLC,IR,NMRに
より純品であると確認した。
S), 4.85 (2H, s), 5.40 (lft,
m) pentenyl)-6-medoxymethoxy 2.5.7
Obtained in Example 19 (EE) in a 10 ml eggplant flask
-Allyl alcohol 120rig (0,34+n+n
ol), S-:1 lysine 92 mg (0,75 mm
o 1) was added and the atmosphere was replaced with nitrogen. In addition, lithium chloride29
mg t'o, 69 mmo I) in dimethylpolamide solution 1.5 mj! was added and cooled in a water bath, then 79 mg (0.69 mmol) of methanesulfonyl chloride was added, and the mixture was stirred for 3.5 hours while being cooled in a water bath. 30% of the reaction solution
- Pour into ice water, extract with ether, wash (saturated Cu(NO)
3), aqueous solution, saturated Na)lc[Is aqueous solution, water), and after drying (MgSIL), the solvent was distilled off to obtain 126 mg of the above-titled target product. This product was confirmed to be pure by TLC, IR, and NMR.

0収率; quant。0 yield; quant.

eIR(neat)cm−’ ; 2920、1250.1160.1060.800.7
50.680・NMR(CDCI 、)δ; 1、24(3H,s)、 1.72(3N、 s)、 
1.57〜1.88(48゜m)、 2.07(3H,
s)、 2.13(3H,s)、 2.16(3H,s
)。
eIR(neat)cm-'; 2920, 1250.1160.1060.800.7
50.680 NMR (CDCI,) δ; 1, 24 (3H, s), 1.72 (3N, s),
1.57-1.88 (48゜), 2.07 (3H,
s), 2.13(3H,s), 2.16(3H,s
).

2、47 (2)1. Ql) 、 2.58 (2H
,t、 J=7Hz) 、 3.57 (3H。
2, 47 (2)1. Ql), 2.58 (2H
, t, J=7Hz), 3.57 (3H.

s>、3.96(2)1.s)、 4.80(2H,s
)、 5.50(IH,t。
s>, 3.96 (2) 1. s), 4.80(2H,s
), 5.50 (IH, t.

J=7Hz) 実施例20で得り(B) −クロJl/体L26mg 
(0,341T1moI)、ゲラニルスルホン200m
g (0,69mmol) 、50%水酸化す) IJ
ウム水溶液0.44gを混ぜ、テトラn−ブチルアンモ
ニウムプロマイY8mg(0,024+y++nol)
を加えてメカニカルスターラーにより1.5時間激しく
撹拌した。反応液に水10mfを加え、エーテル抽出、
洗浄(飽和ブライン)、乾燥後(MgSO3) 、溶媒
留去して粗生成物を得た。
J=7Hz) Obtained in Example 20 (B) - Black Jl/Body L26mg
(0,341T1moI), geranyl sulfone 200m
g (0.69 mmol), 50% hydroxide) IJ
Mix 0.44 g of tetra-n-butylammonium aqueous solution and add 8 mg of tetra n-butylammonium puromy Y (0,024+y++nol).
was added and stirred vigorously for 1.5 hours using a mechanical stirrer. Add 10 mf of water to the reaction solution, extract with ether,
After washing (saturated brine), drying (MgSO3) and evaporation, the crude product was obtained.

これをカラムクロマトグラフィー(シリカゲル6g、溶
出液;10%酢酸エチル/ヘキサン)で精製して上記標
題の目的物を179mg得た。
This was purified by column chromatography (6 g of silica gel, eluent: 10% ethyl acetate/hexane) to obtain 179 mg of the above-mentioned target compound.

・収率:84% oIR(neat)cm−’ ; 2920、1600.1300.1140.810・N
MR(CD[l’13)δ; 1.20(6)1.s)、 1.50(3H,s)、 
1.59(3H,s)。
・Yield: 84% oIR (neat) cm-'; 2920, 1600.1300.1140.810・N
MR(CD[l'13)δ; 1.20(6)1. s), 1.50 (3H, s),
1.59 (3H, s).

1.68(3H,s)、 1.64(2)!、m)、 
1.75 (2H,t、 J=6.6Hz)、 1.9
0(6H,m)、 2.06(3H,s)、 2.13
(3N、s)、 2.17(3H,s)、 2.43(
3)1.s)、 2.56(2H,t、J=6.6Hz
)、 2.73〜2.94(2H,m)、 3.61(
38,s)、 3.70〜3.83(IH,m)、 4
.84(2)1.s)。
1.68 (3H, s), 1.64 (2)! , m),
1.75 (2H, t, J=6.6Hz), 1.9
0 (6H, m), 2.06 (3H, s), 2.13
(3N, s), 2.17 (3H, s), 2.43 (
3)1. s), 2.56 (2H, t, J=6.6Hz
), 2.73-2.94 (2H, m), 3.61 (
38,s), 3.70-3.83(IH,m), 4
.. 84(2)1. s).

4.90〜5.23(3H,m)、 7.28(2H,
d、J=8゜3Hz) 。
4.90-5.23 (3H, m), 7.28 (2H,
d, J=8°3Hz).

7、71 (2H,−d、 J=8.3Hz)実施例2
2 (2R,3’ε、7’E)−6−メドキシメトキシー2
.5.7.81ヱ 30mj!ナスフラスコに実施例21で得たカップリン
グ体175mg(0,28mmol) 、ジクロ0(1
,3−ビス(ジフェニルホスフィノ)フロパン〕ハラジ
ウム(n) 13mg(0,022mmol)を入れ、
テトラヒドロフラン14m1を加えて窒素置換し、Ot
まで冷却した。0℃でリチウムトリエチルボロヒドリド
(1,0Mテトラヒドロフラン溶液)1.4d(1,4
mmol)を加え、室温に戻して3時間撹拌した後、水
を20m1加えて過剰のリチウムトリエチルボロヒドリ
ドをクエンチした。反応液をエーテル抽出、洗浄(飽和
ブライン)、乾燥後(MgS04)、溶媒留去して粗生
成物を得た。これをカラムクロマトグラフィー(シリカ
ゲル1.5g、溶出液;5%酢酸エチル/ヘキサン)で
精製して上記標題の目的物を115mg得た。
7, 71 (2H, -d, J=8.3Hz) Example 2
2 (2R, 3'ε, 7'E)-6-medoxymethoxy 2
.. 5.7.81ヱ30mj! In an eggplant flask were placed 175 mg (0.28 mmol) of the coupling product obtained in Example 21 and 0 (1
,3-bis(diphenylphosphino)furopane]haladium(n) 13 mg (0,022 mmol) was added,
Add 14 ml of tetrahydrofuran and replace with nitrogen.
Cooled to . Lithium triethylborohydride (1,0 M solution in tetrahydrofuran) 1.4 d (1,4
mmol) was added, the mixture was returned to room temperature and stirred for 3 hours, and then 20 ml of water was added to quench excess lithium triethylborohydride. The reaction solution was extracted with ether, washed (saturated brine), dried (MgSO4), and the solvent was distilled off to obtain a crude product. This was purified by column chromatography (1.5 g of silica gel, eluent: 5% ethyl acetate/hexane) to obtain 115 mg of the above-mentioned title compound.

・収率;87% ’ IR(neat)Cm−’ ; 2900、1250.1160.1060・NMR(C
DC13)δ; 1.25(3H,s)、   159(9N、s)、 
  1.68(3tl、s)。
・Yield; 87% 'IR(neat)Cm-'; 2900, 1250.1160.1060・NMR(C
DC13) δ; 1.25 (3H, s), 159 (9N, s),
1.68 (3tl, s).

1、79(2H,t、 J=6.8Hz)、 1.43
〜1.86 (2H,m)。
1, 79 (2H, t, J=6.8Hz), 1.43
~1.86 (2H, m).

2.00(10)1.s)、 2.09(3)1.s)
、 2.14(3H,s)。
2.00(10)1. s), 2.09(3)1. s)
, 2.14 (3H, s).

2.18(3H,s)、 2.59(2H,t、J=6
.8Hz)、 3.61(3H,s)、 4.85(2
H,s)、 5.1HIH,m)(2R,3′8.7°
E)−α−トコトリエノールlO−ナスフラスコに実施
例22で得たα−トコトリエノールメトキシメチルエー
テル体110fng(0,23mmol)を入れ、イソ
プロピルアルコール3.5mj!に溶かし、4N塩酸0
.6−を加え室温で20時間撹拌した。反応液を水20
mj’にあけ、エーテル抽出、洗浄(水)、乾燥後(M
gSL) 、溶媒留去して粗生成物を得た。これをカラ
ムクロマトグラフィー(シリカゲル2g、溶出液:工%
酢酸エチル/ヘキサン)で精製して上記標題の(2R,
3°E、7′ε)−α−トコトリエノールを93mg得
た。
2.18 (3H, s), 2.59 (2H, t, J=6
.. 8Hz), 3.61 (3H, s), 4.85 (2
H,s), 5.1HIH,m)(2R,3'8.7°
E) -α-Tocotrienol 110 fng (0.23 mmol) of the α-tocotrienol methoxymethyl ether obtained in Example 22 was placed in an O-bottom flask, and 3.5 mj of isopropyl alcohol was added. Dissolve in 4N hydrochloric acid 0
.. 6- was added and stirred at room temperature for 20 hours. Add 20% of the reaction solution to water.
After extraction with ether, washing (water), and drying (M
gSL) and the solvent was distilled off to obtain a crude product. This was subjected to column chromatography (2 g of silica gel, eluent:
(ethyl acetate/hexane) to obtain the above title (2R,
93 mg of 3°E, 7′ε)-α-tocotrienol was obtained.

・収 率;93% ・[α]P−4,53°(Cm1.61. CHCl3
)、 79%e、e。
・Yield; 93% ・[α]P-4,53°(Cm1.61.CHCl3
), 79% e, e.

く文献値〉 〔α3g5=−5,71°(Cm1゜01155. C
H[”L)oIR(neat)c+n ’ ; 345
0・NMR(CDC13)δ; 1.26(38,s)、 1.59(9H,s)、 1
.68(3H,s>。
Literature value> [α3g5=-5,71°(Cm1°01155.C
H[”L)oIR(neat)c+n'; 345
0.NMR (CDC13) δ; 1.26 (38, s), 1.59 (9H, s), 1
.. 68 (3H, s>.

180(2H,t、J=7)1z)、 2.00(3)
1.s)、 2.11(3)l。
180 (2H, t, J = 7) 1z), 2.00 (3)
1. s), 2.11(3)l.

s)、 2.16(3)1.s)、 2.00〜2.1
6(12N、m)。
s), 2.16(3)1. s), 2.00-2.1
6 (12N, m).

2.61(2H,t、J=7Hz)、 4.18(LH
,s)、 5.13(3H。
2.61 (2H, t, J=7Hz), 4.18 (LH
, s), 5.13 (3H.

m)m)

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ (式中、Rは水酸基の保護基を示す) で表される化合物を脱硫反応せしめて、次の一般式 ▲数式、化学式、表等があります▼ (式中、Rは前記の意味を有する) で表される化合物を得、次いで得られた化合物の水酸基
の保護基を脱離することを特徴とする下記の構造式(
I )で表される光学活性α−トコトリエノールの製造方
法。 ▲数式、化学式、表等があります▼( I )
[Claims] 1 A compound represented by the general formula ▲ includes numerical formulas, chemical formulas, tables, etc. ▼ (in the formula, R represents a protecting group for a hydroxyl group) is subjected to a desulfurization reaction to produce the following general formula ▲ mathematical formula, There are chemical formulas, tables, etc. ▼ (In the formula, R has the above meaning) The following structural formula is characterized by obtaining a compound represented by and then removing the protecting group of the hydroxyl group of the obtained compound. (
A method for producing optically active α-tocotrienol represented by I). ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I)
JP5798688A 1988-03-11 1988-03-11 Method for producing optically active α-tocotrienol Expired - Lifetime JP2685785B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5798688A JP2685785B2 (en) 1988-03-11 1988-03-11 Method for producing optically active α-tocotrienol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5798688A JP2685785B2 (en) 1988-03-11 1988-03-11 Method for producing optically active α-tocotrienol

Publications (2)

Publication Number Publication Date
JPH01233278A true JPH01233278A (en) 1989-09-19
JP2685785B2 JP2685785B2 (en) 1997-12-03

Family

ID=13071331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5798688A Expired - Lifetime JP2685785B2 (en) 1988-03-11 1988-03-11 Method for producing optically active α-tocotrienol

Country Status (1)

Country Link
JP (1) JP2685785B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7038067B2 (en) 2003-10-10 2006-05-02 Yasoo Health, Inc. Process for synthesizing d-tocotrienols from 2-vinylchromane compound
WO2013013078A1 (en) 2011-07-19 2013-01-24 Edison Pharmeceuticals, Inc. Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
EP2609921A1 (en) 2009-06-25 2013-07-03 Ampere Life Sciences, Inc. Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
US8653144B2 (en) 2008-09-10 2014-02-18 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
EP2963006A1 (en) 2008-10-28 2016-01-06 Edison Pharmaceuticals, Inc. Composition containing alpha-tocotrienol quinone,and intermediates thereof
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9370496B2 (en) 2009-04-28 2016-06-21 Edison Pharmaceuticals, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US10745371B2 (en) 2015-12-16 2020-08-18 Ptc Therapeutics, Inc. Methods for enriching alpha-tocotrienol from mixed tocol compositions

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7038067B2 (en) 2003-10-10 2006-05-02 Yasoo Health, Inc. Process for synthesizing d-tocotrienols from 2-vinylchromane compound
US11021424B2 (en) 2005-06-01 2021-06-01 Ptc Therapeutics, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9447006B2 (en) 2005-06-01 2016-09-20 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9932286B2 (en) 2006-02-22 2018-04-03 Bioelectron Technology Corporation Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US10105325B2 (en) 2008-09-10 2018-10-23 Bioelectron Technology Corporation Treatment of pervasive developmental disorders with redox-active therapeutics
US8653144B2 (en) 2008-09-10 2014-02-18 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US10736857B2 (en) 2008-09-10 2020-08-11 Ptc Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US9399612B2 (en) 2008-09-10 2016-07-26 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
US8969420B2 (en) 2008-09-10 2015-03-03 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
EP3450431A1 (en) 2008-10-28 2019-03-06 BioElectron Technology Corporation Process for the production of alpha-tocotrienol and derivatives
EP2963006A1 (en) 2008-10-28 2016-01-06 Edison Pharmaceuticals, Inc. Composition containing alpha-tocotrienol quinone,and intermediates thereof
US11312697B2 (en) 2008-10-28 2022-04-26 Ptc Therapeutics, Inc. Process for the production of alpha-tocotrienol and derivatives
US10071978B2 (en) 2008-10-28 2018-09-11 Bioelectron Technology Corporation Process for the production of alpha-tocotrienol and derivatives
US10195161B2 (en) 2009-04-28 2019-02-05 Bioelectron Technology Corporation Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
US9370496B2 (en) 2009-04-28 2016-06-21 Edison Pharmaceuticals, Inc. Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
EP2609921A1 (en) 2009-06-25 2013-07-03 Ampere Life Sciences, Inc. Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
WO2013013078A1 (en) 2011-07-19 2013-01-24 Edison Pharmeceuticals, Inc. Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
US10745371B2 (en) 2015-12-16 2020-08-18 Ptc Therapeutics, Inc. Methods for enriching alpha-tocotrienol from mixed tocol compositions
US11186559B2 (en) 2015-12-16 2021-11-30 Ptc Therapeutics, Inc. Methods for enriching alpha-tocotrienol from mixed tocol compositions
US11560364B2 (en) 2015-12-16 2023-01-24 Ptc Therapeutics, Inc. Methods for enriching alpha-tocotrienol from mixed tocol compositions
US10981855B2 (en) 2015-12-17 2021-04-20 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US11680034B2 (en) 2015-12-17 2023-06-20 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Also Published As

Publication number Publication date
JP2685785B2 (en) 1997-12-03

Similar Documents

Publication Publication Date Title
CA1278303C (en) Process for the preparation of taxol and 10-desacetyl taxol
EP0336840B1 (en) Process for the preparation of taxol
JPH01233278A (en) Production of optically active alpha-tocotrienol
JP2002509926A (en) Novel ascorbic acid derivative and preparation method thereof
JP2000510470A (en) 1-Deoxybaccatin III, 1-deoxytaxol and 1-deoxytaxol analogs, and methods for their preparation
JPS6363674A (en) Production of optical active alpha-tocotrienol
JP2001247594A (en) Method of producing flavonoid compound
US5504219A (en) Optically active compounds and intermediates thereof, and process for manufacturing same
JPH0684367B2 (en) New method for producing forskolin derivative
EP0177398B1 (en) Chlorinated derivatives of hexadecene, their preparation and their use in the synthesis of vitamin e
US5914410A (en) Intermediates for annonaceous acetogenins
JP2620251B2 (en) Method for producing chroman derivative
US5233056A (en) Optically active chroman derivatives and intermediates thereof, and process for manufacturing same
JP3029840B2 (en) Method for producing optically active chroman-2-ethanol derivative and intermediate thereof
CA1253163A (en) Process for the preparation of tocopherol derivatives, and derivatives thus obtained
ITRM20110418A1 (en) PROCESS FOR THE PREPARATION OF EPOXY WHICH INTERMEDIATES FOR THE SYNTHESIS OF NEBIVOLOL.
JP6560049B2 (en) Process for producing lenteztrehalose A, compound useful for the process and process for producing the same
JPH03123780A (en) 2h-benzo(b)quinolidine derivative
Wu et al. Synthesis of two novel chiral building blocks for anti-and syn-1, 3-diols
CN115304589A (en) Preparation method of canagliflozin impurity
JPH03246242A (en) Optically active pentane derivative
JPS6219589A (en) Production of hamaudol
CN116514759A (en) Synthesis method of dihydromyricetin
JP2718546B2 (en) Stereoselective production of cyclopentenone derivatives
JPH08295682A (en) Baccatin derivative and its production